Doctors Note Logo

Published on: 9/15/2026

Can peripheral artery disease lead to amputation or a heart attack?

Yes, peripheral artery disease can lead to amputation and heart attack, because the same plaque buildup narrowing your leg arteries usually affects the arteries feeding your heart and brain. In advanced cases called critical limb ischemia, poor blood flow causes rest pain, non-healing sores, or gangrene that may require amputation, while roughly 1 in 3 people with PAD face a major cardiovascular event such as heart attack or stroke. Risk depends on several factors, including smoking, diabetes, cholesterol, blood pressure, and how early the disease is caught, and outcomes improve dramatically with treatment, so review the important warning signs and prevention details below before drawing conclusions.

Leg cramping when you walk, cold or discolored feet, or a wound that will not heal deserve attention now rather than later, since early diagnosis is what separates manageable PAD from limb-threatening disease. Take a free, instant, online symptom check to better understand what may be causing your symptoms and what steps to take next.

Last reviewed for medical accuracy: 09/14/2026

answer background

Explanation

Can Peripheral Artery Disease Lead to Amputation or a Heart Attack?

Peripheral artery disease (PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to your limbs. The most common cause of PAD is atherosclerosis—the buildup of fatty plaques on artery walls. Understanding the risks and progression of PAD can help you recognize warning signs early and take steps to protect your health.

What Is Atherosclerosis and How Does It Cause PAD?

Atherosclerosis is a process where cholesterol, fat, calcium and other substances accumulate on the inner walls of arteries. Over time, these plaques:

  • Harden and narrow the arteries (stenosis)
  • Reduce blood and oxygen supply to tissues
  • Become unstable and potentially rupture, forming blood clots

When atherosclerosis affects the arteries supplying your legs or feet, it leads to PAD. The same underlying process can affect coronary arteries (leading to heart attack) or carotid arteries (leading to stroke).

Early Signs and Diagnosis of PAD

Many people with PAD have mild or no symptoms at first. Common warning signs include:

  • Intermittent claudication: Cramping, pain or tiredness in leg muscles during activity that eases with rest
  • Coldness or numbness in lower leg or foot, especially when compared with the other side
  • Sores or ulcers on toes, feet or legs that heal slowly or not at all
  • Weak or absent pulses in legs or feet

To confirm PAD, healthcare providers may use:

  • Ankle–brachial index (ABI): Compares blood pressure in ankle vs. arm
  • Doppler ultrasound: Examines blood flow in leg vessels
  • Angiography (CT or MR angiogram): Visualizes artery blockages

Early detection is key. If you suspect leg pain or notice non-healing wounds, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.

How PAD Raises the Risk of Heart Attack

Atherosclerosis is a systemic condition—if plaque is building in your leg arteries, it’s likely present elsewhere, including the heart. Key points:

  • People with PAD have up to a sixfold increased risk of coronary artery disease (CAD).
  • CAD can lead to myocardial infarction (heart attack) when a plaque ruptures and a clot blocks a coronary artery.
  • PAD is often a “red flag” for more widespread vascular disease; even without leg symptoms, it signals higher cardiovascular risk.

Because of this overlap:

  • Managing cholesterol, blood pressure and blood sugar is critical to slow atherosclerosis everywhere.
  • Regular cardiac risk assessment helps catch silent heart disease before it becomes an emergency.

When PAD Progresses to Critical Limb Ischemia and Amputation Risk

In advanced PAD, called critical limb ischemia (CLI), blood flow is so restricted that tissues begin to die. Warning signs include:

  • Pain in feet or toes at rest, often worsening at night
  • Non-healing ulcers or gangrene on toes, feet or lower legs
  • Skin discoloration, thinning, or shiny appearance

Without timely treatment, CLI can lead to:

  • Severe infection
  • Tissue death (necrosis)
  • Need for limb amputation

Statistics show:

  • Approximately 1 in 10 patients with PAD will develop CLI over five years.
  • Of those with CLI, up to 50% may require amputation if revascularization is not possible or delayed.

It’s important to remember that amputation is generally a last resort—doctors aim to restore blood flow whenever possible.

Preventing Heart Attack and Amputation in PAD

The goal in PAD management is to improve blood flow, relieve symptoms and lower cardiovascular risk. Key strategies include:

Lifestyle Modifications

  • Quit smoking: Smoking accelerates atherosclerosis and doubles PAD progression risk.
  • Exercise regularly: Supervised walking programs can increase pain-free walking distance.
  • Heart-healthy diet: Emphasize fruits, vegetables, whole grains, lean proteins and healthy fats.

Medications

  • Antiplatelet agents (e.g., aspirin or clopidogrel) to reduce clot risk
  • Statins to lower LDL (“bad”) cholesterol and stabilize plaques
  • Blood pressure control (ACE inhibitors, ARBs, beta-blockers)
  • Medications for claudication (e.g., cilostazol) to improve walking distance

Interventional Treatments

  • Angioplasty and stenting: A balloon widens the artery; a stent keeps it open.
  • Atherectomy: Specialized devices remove plaque directly.
  • Bypass surgery: A graft reroutes blood around a blocked artery.

Successful intervention not only eases leg symptoms but also reduces the chance of heart attack by improving overall vascular health.

Monitoring and Follow-Up

Living with PAD requires ongoing care:

  • Regular check-ups every 6–12 months (or as directed)
  • Periodic ABI or ultrasound to assess blood flow
  • Monitoring for new or worsening symptoms

If you notice sudden intensification of leg pain, non-healing wounds or chest discomfort, seek medical attention promptly. You can start by doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to determine urgency.

Key Takeaways

  • Atherosclerosis underlies both PAD and coronary artery disease.
  • PAD raises your risk of heart attack and, in severe cases, limb amputation.
  • Early detection—through symptom awareness and tests like ABI—is vital.
  • Lifestyle changes, medications and interventional procedures can prevent progression.
  • Regular follow-up helps catch complications before they become life-threatening.

Always discuss any new or worsening symptoms with your healthcare provider. If you experience signs of critical limb ischemia (rest pain, non-healing ulcers) or cardiac symptoms (chest pain, shortness of breath), it’s essential to act quickly. Use a free, online symptom check, using the doctor approved Ubie Symptom Checker, then speak to a doctor about anything that could be life threatening or serious.

(References)

  • * Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S, COMPASS Investigators. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. PMID: 29132880.

  • * Höbaus C, Pesau G, Herz CT, Wrba T, Koppensteiner R, Schernthaner GH. Angiopoietin-2 and Survival in Peripheral Artery Disease Patients. Thromb Haemost. 2018 Apr;118(4):791-797. doi: 10.1055/s-0038-1636543. Epub 2018 Apr 4. PMID: 29618157.

  • * Giugliano RP, Pedersen TR, Saver JL, Sever PS, Keech AC, Bohula EA, Murphy SA, Wasserman SM, Honarpour N, Wang H, Lira Pineda A, Sabatine MS, FOURIER Investigators. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis. Stroke. 2020 May;51(5):1546-1554. doi: 10.1161/STROKEAHA.119.027759. Epub 2020 Apr 21. PMID: 32312223.

  • * Bonaca MP, Hamburg NM, Creager MA. Contemporary Medical Management of Peripheral Artery Disease. Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10. PMID: 34110910.

  • * Shamaki GR, Markson F, Soji-Ayoade D, Agwuegbo CC, Bamgbose MO, Tamunoinemi BM. Peripheral Artery Disease: A Comprehensive Updated Review. Curr Probl Cardiol. 2022 Nov;47(11):101082. doi: 10.1016/j.cpcardiol.2021.101082. Epub 2021 Dec 11. PMID: 34906615.

  • * Lingvay I, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lincoff AM, Marso SP, Fries TM, Plutzky J, Ryan DH, SELECT Study Group. Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics. Obesity (Silver Spring). 2023 Jan;31(1):111-122. doi: 10.1002/oby.23621. Epub 2022 Dec 10. PMID: 36502289; PMCID: PMC10107832.

  • * Maldonado TS, Powell A, Wendorff H, Rowse J, Nagarsheth KH, Dexter DJ, Dietzek AM, Muck PE, Arko FR, Chung J, STRIDE study group. Safety and efficacy of mechanical aspiration thrombectomy for patients with acute lower extremity ischemia. J Vasc Surg. 2024 Mar;79(3):584-592.e5. doi: 10.1016/j.jvs.2023.10.062. Epub 2023 Nov 4. PMID: 37931885.

  • * Luo J, Thomassen JQ, Nordestgaard BG, Tybjærg-Hansen A, Frikke-Schmidt R. Neutrophil counts and cardiovascular disease. Eur Heart J. 2023 Dec 14;44(47):4953-4964. doi: 10.1093/eurheartj/ehad649. PMID: 37950632; PMCID: PMC10719495.

  • * Dutta D, Mohindra R, Kumar M, Banerjee M, Sharma M, Mukhopadhyay S. Cardiovascular safety of gabapentinoids gabapentin & pregabalin: A systematic review. Indian J Med Res. 2025 Apr;161(4):363-374. doi: 10.25259/IJMR_1990_2024. PMID: 40536375; PMCID: PMC12178190.

  • * Badve SV, Perkovic V, Jha V, Ramachandran R, Mushahar L, Menne J, De Vriese AS, Rossignol P, Flahault A, Al Ammari M, Skhiri H, Walsh M, Collister D, Liew A, Billot L, Bompoint S, Devaux A, Jun M, Lin E, Ramos da Cruz A, Ha JT, Eikelboom JW, Shaman A, Jardine MJ, Jesudason S, Wong MG, Anderson CS, Garg AX, Heerspink HJL, Monaghan H, Patel A, Mark PB, Wheeler DC, Lv J, Zuo L, Pilmore H, Gallagher M, TRACK Trial Investigators. Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial. JAMA. 2026 Jul 28;336(4):296-305. doi: 10.1001/jama.2026.9379. PMID: 42240165; PMCID: PMC13237706.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.